Cellectis (CLLS) Change in Acquisitions & Divestments (2016 - 2024)
Cellectis' (CLLS) quarterly Change in Acquisitions & Divestments came in at -$105.4 million in Q2 2024, down 6128.9% quarter-over-quarter from -$1.7 million in Q1 2024.
Cellectis (CLLS) Change in Acquisitions & Divestments (2016 - 2024) Analysis & Trends
Cellectis' Change in Acquisitions & Divestments history runs 8 years deep, the most recent figure standing at -$105.4 million for Q2 2024.
- On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to -$105.4 million in Q2 2024; TTM through Jun 2024 was -$107.0 million, a N/A change from a year earlier, with the FY2023 full-year figure at -$13.4 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments slipped to -$105.4 million in Q2 2024 per CLLS's latest filing, from -$1.7 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $25.9 million in Q4 2020 and bottomed at -$105.4 million in Q2 2024.
- The 4-year median for Change in Acquisitions & Divestments is $1.7 million (2021), against an average of -$7.3 million.
- Biggest YoY gain for Change in Acquisitions & Divestments was 862800.0% in 2020; the steepest drop was 23939.51% in 2020.
- Year by year, Change in Acquisitions & Divestments stood at $25.9 million in 2020, then sank by 145.25% to -$11.7 million in 2021, then jumped by 97.21% to -$326000.0 in 2022, then slumped by 32229.14% to -$105.4 million in 2024.
- Per Business Quant, the three latest CLLS Change in Acquisitions & Divestments figures stand at -$105.4 million (Q2 2024), -$1.7 million (Q1 2024), and -$326000.0 (Q4 2022).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Cellectis | 285.50 Mn | 99.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -105.39 Mn |
| Jun 30, 2024 | -105.39 Mn |
| Mar 31, 2024 | -1.69 Mn |
| Mar 31, 2024 | -1.69 Mn |
| Dec 31, 2022 | -326,000.00 |
| Dec 31, 2022 | -326,000.00 |
| Sep 30, 2022 | 372,000.00 |
| Sep 30, 2022 | 372,000.00 |
| Dec 31, 2021 | -11.70 Mn |
| Dec 31, 2021 | -11.70 Mn |
| Sep 30, 2021 | 3.00 Mn |
| Sep 30, 2021 | 3.00 Mn |
| Jun 30, 2021 | 15.05 Mn |
| Jun 30, 2021 | 15.05 Mn |
| Mar 31, 2021 | 8.65 Mn |
| Mar 31, 2021 | 8.65 Mn |
| Dec 31, 2020 | 25.85 Mn |
| Dec 31, 2020 | 25.85 Mn |
| Sep 30, 2020 | 9.14 Mn |
| Sep 30, 2020 | 9.14 Mn |